PET/MRI in Predicting the Outcome of Neoadjuvant Chemoradiotherapy With Esophagectomy in Esophageal Cancer Patients - Trial NCT05855291
Access comprehensive clinical trial information for NCT05855291 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung Memorial Hospital and is currently Completed. The study focuses on Esophageal Cancer. Target enrollment is 43 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chang Gung Memorial Hospital
Timeline & Enrollment
N/A
Jan 22, 2018
Jul 31, 2021
Primary Outcome
Overall survival
Summary
Integrated PET/MRI has the advantage to assess the metabolism, diffusion, and perfusion
 parameters of the tumor simultaneously. Recently, PET/MRI has been investigated in several
 cancers with promising results. In this study, we prospectively investigate the role of
 multiparametric PET/MRI in evaluating the outcome of patients with esophageal cancer treated
 by neoadjuvant chemoradiotherapy and surgery.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05855291
Non-Device Trial